NPI: 1306812771 · TORRINGTON, CT 06790 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/27/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/27/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,892 | $186K |
| 2019 | 18,555 | $123K |
| 2020 | 14,168 | $69K |
| 2021 | 14,854 | $96K |
| 2022 | 11,748 | $14K |
| 2023 | 5,624 | $39K |
| 2024 | 1,676 | $877.70 |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 83970 | 1,220 | 1,039 | $134K | |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 25,636 | 2,063 | $108K |
| 82728 | 662 | 581 | $77K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 14,016 | 1,053 | $62K |
| 83550 | 580 | 508 | $45K | |
| 83540 | 696 | 602 | $36K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 29,433 | 1,390 | $29K |
| 85041 | 1,714 | 1,497 | $13K | |
| A4657 | Syringe, with or without needle, each | 1,982 | 1,697 | $10K |
| 85048 | 1,706 | 1,491 | $9K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 322 | 168 | $3K |
| J1756 | Injection, iron sucrose, 1 mg | 5,211 | 1,186 | $2K |
| 90674 | 60 | 54 | $354.30 | |
| G0008 | Administration of influenza virus vaccine | 67 | 62 | $306.30 |
| 85045 | 17 | 12 | $196.78 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 145 | 116 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 25 | 14 | $0.00 |
| 90670 | 25 | 14 | $0.00 |